1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Typhoid Fever Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Incidence and Mortality of Typhoid Accelerate Demand for Typhoid Conjugate Vaccines
5.2 Market Opportunities
- 5.2.1 Combination Vaccines
5.3 Future Trends
- 5.3.1 Government Support for the Typhoid Immunization to Favor Market
5.4 Impact of Drivers and Restraints
6. North America Typhoid Fever Vaccines Market Regional Analysis
6.1 North America Typhoid Fever Vaccines Market Overview
6.2 North America Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 North America Typhoid Fever Vaccines Market Forecast Analysis
7. North America Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Typhoid Fever Vaccines Market – North America Analysis
9.1 North America
- 9.1.1 North America Typhoid Fever Vaccines Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 North America Typhoid Fever Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 US: North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.1.2 US: North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.2 Canada:
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Canada: North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.2.2 Canada: North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.1.1.3 Mexico :
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Mexico : North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.1.1.3.2 Mexico : North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Typhoid Fever Vaccines Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Sanofi
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Paxvax Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Prokarium Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Scandinavian Biopharma
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Typhoid Fever Vaccines Market
